SI2913394T1 - Ko-diferenciacija in aktivacija monocitov iz alogenskih darovalcev za zagotovitev proinflamatornih dendričnih celic - Google Patents

Ko-diferenciacija in aktivacija monocitov iz alogenskih darovalcev za zagotovitev proinflamatornih dendričnih celic

Info

Publication number: SI2913394T1
Authority: SI; Slovenia
Prior art keywords: monocytes; differentiation; activation; dendritic cells; allogeneic donors
Prior art date: 2012-12-18

Application number

SI201330281A

Other languages

English (en)

Inventor

Alex Karlsson-Parra

Bengt Andersson

Original Assignee

Immunicum Ab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2012-12-18

Filing date

2013-12-18

Publication date

2017-01-31

2013-12-18 Application filed by Immunicum Ab filed Critical Immunicum Ab

2017-01-31 Publication of SI2913394T1 publication Critical patent/SI2913394T1/sl

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/14—Blood; Artificial blood
- A61K35/15—Cells of the myeloid line, e.g. granulocytes, basophils, eosinophils, neutrophils, leucocytes, monocytes, macrophages or mast cells; Myeloid precursor cells; Antigen-presenting cells, e.g. dendritic cells
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
- C12N5/0639—Dendritic cells, e.g. Langherhans cells in the epidermis
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/40—Nucleotides, nucleosides or bases
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/20—Cytokines; Chemokines
- C12N2501/22—Colony stimulating factors (G-CSF, GM-CSF)
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/20—Cytokines; Chemokines
- C12N2501/23—Interleukins [IL]
- C12N2501/2304—Interleukin-4 (IL-4)
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/20—Cytokines; Chemokines
- C12N2501/24—Interferons [IFN]
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
- C12N2506/11—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from blood or immune system cells
- C12N2506/115—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from blood or immune system cells from monocytes, from macrophages

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Biomedical Technology (AREA)
Immunology (AREA)
Chemical & Material Sciences (AREA)
Zoology (AREA)
Biotechnology (AREA)
Hematology (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Cell Biology (AREA)
Genetics & Genomics (AREA)
Bioinformatics & Cheminformatics (AREA)
Wood Science & Technology (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Epidemiology (AREA)
Microbiology (AREA)
Biochemistry (AREA)
General Engineering & Computer Science (AREA)
Developmental Biology & Embryology (AREA)
Virology (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

SI201330281A 2012-12-18 2013-12-18 Ko-diferenciacija in aktivacija monocitov iz alogenskih darovalcev za zagotovitev proinflamatornih dendričnih celic SI2913394T1 (sl)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
EP12197687		2012-12-18
EP15161369.2A EP2913394B1 (en)	2012-12-18	2013-12-18	Co-differentiation and activation of monocytes from allogeneic donors to provide pro-inflammatory dendritic cells

Publications (1)

Publication Number	Publication Date
SI2913394T1 true SI2913394T1 (sl)	2017-01-31

Family

ID=47427250

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
SI201330281A SI2913394T1 (sl)	2012-12-18	2013-12-18	Ko-diferenciacija in aktivacija monocitov iz alogenskih darovalcev za zagotovitev proinflamatornih dendričnih celic
SI201330066T SI2788474T1 (sl)	2012-12-18	2013-12-18	Ko-diferenciacija monocitov iz alogenskih darovalcev

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
SI201330066T SI2788474T1 (sl)	2012-12-18	2013-12-18	Ko-diferenciacija monocitov iz alogenskih darovalcev

Country Status (16)

Country	Link
US (2)	US9714413B2 (sl)
EP (2)	EP2788474B1 (sl)
JP (1)	JP6529439B2 (sl)
KR (1)	KR102148051B1 (sl)
CN (2)	CN105452449B (sl)
AU (1)	AU2013360793B2 (sl)
BR (1)	BR112015014270B1 (sl)
CA (1)	CA2895280C (sl)
DK (2)	DK2788474T3 (sl)
ES (2)	ES2591230T3 (sl)
HU (2)	HUE028895T2 (sl)
MX (1)	MX357491B (sl)
PL (2)	PL2913394T3 (sl)
RU (1)	RU2668816C2 (sl)
SI (2)	SI2913394T1 (sl)
WO (1)	WO2014096033A1 (sl)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP3460052B1 (en)	2017-09-20	2019-10-30	Immunicum AB	Improved allogeneic dendritic cells for use in cancer treatment
US12329807B2 (en)	2018-01-18	2025-06-17	Meganano Biotech, Inc.	Dead antigen stimulated immature heterogenous dendritic cells as therapeutics for diseases
CN108660125A (zh) *	2018-05-14	2018-10-16	武汉博百欧生物科技有限公司	一种从人体输血废弃物中提取中性粒细胞嗜天青颗粒的方法
US20220106566A1 (en) *	2019-01-22	2022-04-07	The Brigham And Women`S Hospital, Inc.	Antigen-Presenting Neutrophil-Derived Dendritic Cells and Methods of Use Thereof

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2001051617A1 (en) *	2000-01-11	2001-07-19	Maxygen, Inc.	Monocyte-derived dendritic cell subsets
AU2002326463A1 (en) *	2001-07-25	2003-02-17	Northwest Biotherapeutics, Inc.	Methods and apparatus for enrichment and culture of monocytic dendritic cell precursors
DK1509244T3 (da)	2002-06-06	2011-10-24	Immunicum Ab	Ny fremgangsmåde og præparat til at producere en cellulær allogen vaccine
KR100585456B1 (ko) *	2003-09-30	2006-06-07	국립암센터	동종 종양-관련 항원이 탑재된 수지상세포, 이의 제조방법및 이를 유효성분으로 하는 암 치료용 백신 조성물
CA2504451A1 (en) *	2004-08-10	2006-02-10	Geron Corporation	Dendritic cell vaccines for treating cancer made from embryonic stem cells
EP3072958A1 (en) *	2005-12-08	2016-09-28	NorthWest Biotherapeutics, Inc.	Compositions and methods for inducing the activation of immature monocytic dendritic cells
EP1806395A1 (en) *	2006-01-06	2007-07-11	Stichting Sanquin Bloedvoorziening	Maturation of dendritic cells
EP1840206A1 (en) *	2006-03-28	2007-10-03	Gsf-Forschungszentrum Für Umwelt Und Gesundheit, Gmbh	Compositions for the preparation of mature dendritic cells
BR112012009962A2 (pt) *	2009-10-27	2015-09-15	Immunicum Ab	método para a proliferação de células tantígeno específicas.
HUE028352T2 (en) *	2010-02-10	2016-12-28	Immunicum Ab	An improved composition for inhibiting tumor cell proliferation
CN103502439B (zh) *	2011-04-13	2016-10-12	因缪尼卡姆股份公司	用于抗原特异性t细胞增殖的方法
JP2014511704A (ja) *	2011-04-13	2014-05-19	イミュニカム・エイビイ	Ｔ細胞のプライミングのための方法

2013
- 2013-12-18 KR KR1020157015766A patent/KR102148051B1/ko not_active Expired - Fee Related
- 2013-12-18 DK DK13814106.4T patent/DK2788474T3/en active
- 2013-12-18 AU AU2013360793A patent/AU2013360793B2/en not_active Ceased
- 2013-12-18 EP EP13814106.4A patent/EP2788474B1/en active Active
- 2013-12-18 CN CN201380066722.0A patent/CN105452449B/zh not_active Expired - Fee Related
- 2013-12-18 HU HUE15161369A patent/HUE028895T2/en unknown
- 2013-12-18 CA CA2895280A patent/CA2895280C/en active Active
- 2013-12-18 SI SI201330281A patent/SI2913394T1/sl unknown
- 2013-12-18 CN CN201910284719.5A patent/CN110042081B/zh not_active Expired - Fee Related
- 2013-12-18 ES ES15161369.2T patent/ES2591230T3/es active Active
- 2013-12-18 MX MX2015007800A patent/MX357491B/es active IP Right Grant
- 2013-12-18 RU RU2015119164A patent/RU2668816C2/ru active
- 2013-12-18 HU HUE13814106A patent/HUE027619T2/en unknown
- 2013-12-18 PL PL15161369.2T patent/PL2913394T3/pl unknown
- 2013-12-18 US US14/653,184 patent/US9714413B2/en active Active
- 2013-12-18 JP JP2015547082A patent/JP6529439B2/ja active Active
- 2013-12-18 SI SI201330066T patent/SI2788474T1/sl unknown
- 2013-12-18 WO PCT/EP2013/077139 patent/WO2014096033A1/en not_active Ceased
- 2013-12-18 PL PL13814106T patent/PL2788474T3/pl unknown
- 2013-12-18 DK DK15161369.2T patent/DK2913394T3/en active
- 2013-12-18 BR BR112015014270-2A patent/BR112015014270B1/pt not_active IP Right Cessation
- 2013-12-18 ES ES13814106.4T patent/ES2548229T3/es active Active
- 2013-12-18 EP EP15161369.2A patent/EP2913394B1/en active Active
2017
- 2017-06-15 US US15/623,530 patent/US10626371B2/en active Active

Also Published As

Publication number	Publication date
JP6529439B2 (ja)	2019-06-12
EP2913394B1 (en)	2016-06-22
CN110042081A (zh)	2019-07-23
MX357491B (es)	2018-07-11
BR112015014270B1 (pt)	2018-12-04
WO2014096033A1 (en)	2014-06-26
US9714413B2 (en)	2017-07-25
EP2913394A1 (en)	2015-09-02
EP2788474B1 (en)	2015-06-24
HUE028895T2 (en)	2017-02-28
ES2548229T3 (es)	2015-10-15
MX2015007800A (es)	2016-01-12
JP2016501529A (ja)	2016-01-21
RU2015119164A (ru)	2017-01-26
CN105452449B (zh)	2019-05-07
BR112015014270A2 (pt)	2015-11-03
US20170321189A1 (en)	2017-11-09
CN110042081B (zh)	2023-09-01
AU2013360793A1 (en)	2015-06-11
PL2913394T3 (pl)	2016-12-30
CN105452449A (zh)	2016-03-30
CA2895280C (en)	2021-04-06
CA2895280A1 (en)	2014-06-26
US20150329823A1 (en)	2015-11-19
PL2788474T3 (pl)	2015-12-31
DK2913394T3 (en)	2016-09-19
US10626371B2 (en)	2020-04-21
RU2668816C2 (ru)	2018-10-02
DK2788474T3 (en)	2015-09-28
KR20150122624A (ko)	2015-11-02
AU2013360793B2 (en)	2019-01-31
SI2788474T1 (sl)	2016-01-29
ES2591230T3 (es)	2016-11-25
EP2788474A1 (en)	2014-10-15
HUE027619T2 (en)	2016-10-28
KR102148051B1 (ko)	2020-08-25

Publication	Publication Date	Title
IL264455A (en)	2019-02-28	Progenitor cells of mesodermal lineage
IL237479A0 (en)	2015-04-30	Methods and compositions relating to eukaryotic cell modulators
IL233980A0 (en)	2014-09-30	Compositions and methods for producing a persistent population of t cells useful for the treatment of cancer
SG11201408697QA (en)	2015-02-27	Methods and compositions for natural killer cells
SG10201705024PA (en)	2017-07-28	Methods and compositions for separating or enriching cells
ZA201404483B (en)	2015-09-30	Improvements in or relating to the encapsulation of perfumes
SI3321355T1 (sl)	2021-11-30	Postopki in sestavki za klinično izpeljavo alogenske celice in terapevtske uporabe
PL2683390T3 (pl)	2018-04-30	Kompozycje i sposoby przeszczepiania mikrobioty okrężnicy
IL238943B (en)	2018-04-30	Controlled release preparations and methods of using them
EP2585999A4 (en)	2014-03-12	ACCELERATE SOCIAL INTERACTIONS
EP2906286A4 (en)	2016-07-20	SILVER NANOPLATE COMPOSITIONS AND METHODS
SG11201501499SA (en)	2015-03-30	Multi-functional compositions and methods of use
EP3052085A4 (en)	2017-07-05	Nanoparticle based artificial antigen presenting cell mediated activation of nkt cells
GB201200458D0 (en)	2012-02-22	Methods of preparing cells and compositions
IL231663A0 (en)	2014-05-28	Vaccines directed at presenting dendritic cells
GB2484517B (en)	2016-03-30	Improvements in and relating to charged particle beam devices
IL222343A0 (en)	2012-12-31	Compositions comprising allogeneic th1 cells and uses thereof
SI2913394T1 (sl)	2017-01-31	Ko-diferenciacija in aktivacija monocitov iz alogenskih darovalcev za zagotovitev proinflamatornih dendričnih celic
SG11201500139SA (en)	2015-02-27	Derivation and self-renewal of isi1+ cells and uses thereof
HUE045495T2 (hu)	2019-12-30	Szabályozott felszabadulású készítmények és alkalmazási eljárásaik
IL233961A0 (en)	2014-09-30	The composition of a phytogenic supplement and methods of its use
EP2885001A4 (en)	2016-02-24	NEW CELL COMPOSITIONS AND METHODS
IL233873A (en)	2017-02-28	Methods for soaking up immune tolerance to organ transplants
ZA201400696B (en)	2017-05-31	Progenitor cells of mesodermal lineage
GB201205051D0 (en)	2012-05-09	Improvements in or relating to the encapsulation of perfumes